Navigation Links
Chipscreen and HUYA Bioscience to Present Clinical Data on Novel HDAC Inhibitor at the 2009 ASCO Annual Meeting
Date:5/28/2009

SHENZHEN, China and SAN DIEGO, May 28 /PRNewswire/ -- Shenzhen Chipscreen Biosciences, Ltd., and HUYA Bioscience International, LLC, today announced that final data from a Phase 1 trial conducted by Chipscreen of the investigational compound chidamide (CS055/HBI-8000) will be presented at the 2009 American Society of Clinical Oncology (ASCO) Annual Meeting, which will be held from May 29 to June 2, 2009, in Orlando, Florida. Chidamide/HBI-8000 is a novel benzamide class histone deacetylase (HDAC) inhibitor in development by Chipscreen and HUYA for oncology indications. The data to be presented will include safety, pharmacokinetics, and biomarker and anti-tumor activity (abstract #3529).

                  Title:  "Phase 1 study of chidamide (CS055/HBI-8000), a
                          novel histone deacetylase inhibitor, in patients
                          with advanced solid tumors and lymphomas"

    Poster Presentation:  Friday, May 29, 2 pm - 6 pm EDT, Level 3, W315A,
                          Board 13

      Poster Discussion:  Friday, May 29, 5 pm - 6 pm EDT, Level 4, Valencia
                          Room, W415D

Shenzhen Chipscreen Biosciences is a leading China-based biotechnology company that specializes in discovering and developing proprietary small molecule therapeutics for unmet medical needs. The company is utilizing its proprietary chemical genomics-based discovery platform to develop a portfolio of clinical and preclinical stage programs in a number of therapeutic areas. The core competence of the company is the science-driven approach in discovery, strong pipeline building capability, experience with IP, and regulatory expertise. Additional information about the company is available at www.chipscreen.com.

HUYA Bioscience International is a leader in enabling and accelerating the global co-development of no
'/>"/>

SOURCE HUYA Bioscience International, LLC
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Chipscreen Biosciences and HUYA Bioscience Intl Announce Promising Preclincial and Phase I Solid Tumor/Lymphoma Data for Chidamide/HBI-8000, New HDAC Inhibitor for Cancer
2. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
3. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
4. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
5. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
6. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
7. Ardea Biosciences Lead MEK Inhibitor, RDEA119, to Enter Human Clinical Trials in Advanced Cancer Patients
8. Alacrity Biosciences Announces Positive Results from a Phase 2 Study of Its Dry Eye Treatment ALTY-0501
9. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
10. Regado Biosciences Initiates Phase IIa Clinical Study of REG1 Anticoagulation System
11. Regado Biosciences Presents Positive Data From REG1 Anticoagulation System Phase Ic Study at American Heart Association 2007 Scientific Sessions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2014)... 15, 2014   DaVita HealthCare Partners Inc. ... nation,s largest and most innovative health care communities, ... DaVita Clinical Research  (DCR) and  HealthCare Partners Clinical ... its extensive clinical research and data analytics services, ... and end-stage renal disease (ESRD), as well as ...
(Date:12/15/2014)... and BOSTON , December 15, ... GPCR structure-guided drug discovery and development company, is pleased ... the United States relating to ... patents in the US significantly strengthens the global patent ... pharmaceutical markets. The suite of patents recently ...
(Date:12/13/2014)... Research and Markets ( http://www.researchandmarkets.com/research/2r6bmg/drug_injection ... "Drug Injection Devices to 2020" report to ... As new drugs become available ... health conditions, drug developers have increasingly pursued packaging ... and increase the efficiency and reliability with which ...
Breaking Medicine Technology:DaVita Clinical Research and HealthCare Partners Clinical Research to Merge and Expand Clinical Trials and Data Analytics Capabilities 2DaVita Clinical Research and HealthCare Partners Clinical Research to Merge and Expand Clinical Trials and Data Analytics Capabilities 3DaVita Clinical Research and HealthCare Partners Clinical Research to Merge and Expand Clinical Trials and Data Analytics Capabilities 4Heptares Extends Global Patent Protection for GPCR-Focused Drug Discovery Platform With Grant of Core Patents in the United States 2Drug Injection Devices to 2020 2Drug Injection Devices to 2020 3Drug Injection Devices to 2020 4
... treating the diabetes patient, doctors discussed how a ... not enough to reveal an individual,s risk for ... Clinical Endocrinologists (AACE) 18th Annual Meeting & Clinical ... "We need to be more aggressive in treating ...
... Corporation (Nasdaq: BPUR ) announced ... U.S. Naval Medical Research Center (NMRC) by letter that it ... Hemopure(R) [hemoglobin glutamer -- 250 (bovine)] under a proposed protocol ... announced, the study, "Restore Effective Survival in Shock" (RESUS) was ...
Cached Medicine Technology:Taking a Hard-Line Approach to Cardiovascular Risks in the Diabetes Patient 2U.S. Naval Medical Research Center Proposed 'RESUS' Clinical Trial in Trauma Patients Remains on FDA Hold 2U.S. Naval Medical Research Center Proposed 'RESUS' Clinical Trial in Trauma Patients Remains on FDA Hold 3
(Date:12/17/2014)... -- Expectant parents should leave prenatal picture-taking to medical ... Use of ultrasound imaging and heartbeat monitors to get ... agency warns. "Although there is a lack ... and heartbeat monitors, prudent use of these devices by ... FDA biomedical engineer, said in an agency news release. ...
(Date:12/17/2014)... HealthDay Reporter , TUESDAY, Dec. 16, ... America, and work commitment is a big reason why, new ... said Dr. Mathias Basner, an assistant professor of sleep and ... of Medicine. A time-use survey of nearly 125,000 Americans, ... main activity exchanged for sleep. Short sleepers -- those who ...
(Date:12/15/2014)... 15, 2014 South Florida’s leading urgent care ... can be a daze of hassle, hustle, and bustle that ... decking halls, to burns when making special meals and heartburn ... can happen at any time. To prevent this season of ... made a list of helpful and healthful holiday tips to ...
(Date:12/15/2014)... News) -- Expert pilots process visual information more efficiently ... better decisions during landings, a new study shows. ... pilots to master, and 36 percent of all airplane ... final approach and landing. Researchers monitored the brain ... pilots while they were at the controls of a ...
(Date:12/15/2014)... 15, 2014 At the leading, long-established ... AutismOne and Focus Autism will welcome ... research on the effects of toxins to children’s health, ... information. , Luminaries such as Dr. Lucija Tomljenovic ... with esteemed, credentialed colleagues of the United States to ...
Breaking Medicine News(10 mins):Health News:FDA Warns Against Fetal 'Keepsake' Videos 2Health News:Work Steals Valuable Sleep Time, Study Finds 2Health News:Work Steals Valuable Sleep Time, Study Finds 3Health News:MD Now Urgent Care Presents Healthy Holiday Tips 2Health News:MD Now Urgent Care Presents Healthy Holiday Tips 3Health News:Study Shows Why Expert Pilots Are Experts 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 3
... of bird flu had been discovered in a Farm in ... cull thousands more, South Korea’s Farm// Ministry officials said on ... Kim Chang-sub, a top official at the Ministry’s Quarantine department ... avian influenza.' Kim also added that the final results of ...
... a new vaccine that promises protection against a wide range ... using a cell-based technology in 11 weeks time.The vaccine is ... H5N1 virus. ,It is still in the early phase of ... been detected in many countries. It has caused maximum damage ...
... Group (World Against Toys Causing Harm), for the 34th time, ... title 'Most Dangerous Toys of 2006' to watch out for. ... James Swartz, an attorney and director of Boston-based WATCH, which ... toy shelves are potentially stocked with dangerous toys which may ...
... in childhood could face an increased risk of developing ... ,The traditional view has been that psychosis such ... most psychiatrists have believed that social factors cannot have ... new study by the Institute of Psychiatry here examined ...
... McKeith has been reprimanded by the Medicines and Healthcare Regulatory ... a license. The authority said there was a lack of ... the star of Channel 4’s You Are What You Eat, ... Formula Wild Pink for women and Fast Formula Horny for ...
... incident 2 years ago, four persons had to be hospitalized ... with an cosmetic product that was unlicensed. The injection contained ... the lethal dose for humans, reported by The Journal of ... toxin, botox, is used to smoothen out facial wrinkles by ...
Cached Medicine News:Health News:WATCH's 2006 List Of Ten Potentially - Dangerous Toys 2
... An external computer-enhanced microplate reader ... provides automated flexible and rapid ... for accurate and reliable photometric ... or without shaking before reading) ...
... a number of assay steps for ... simple to use benchtop device. The ... stand-alone device but also provides easy ... and standard add-on modules provide maximum ...
... AP-22 Micro Plate Processor is ... Automated Microplate Analyzer. It has been ... assigned area can be customised according ... Micro Plate Processor is able to ...
Grab one and go, One of the smallest handheld oximeters available, Datex-Ohmeda s TuffSat is the ideal spot-check solution for hospital, home care, transport, and EMS. TuffSat comes fully loaded wi...
Medicine Products: